Browsing publications by Dr Mohammed Ebrahimkhani

Newcastle AuthorsTitleYear
Dr Phillip Probert
Dr Mohammed Ebrahimkhani
Dr Fiona Oakley
Dr Jelena Mann
Professor Alastair Burt
et al.
A reversible model for periportal fibrosis and a refined alternative to bile duct ligation2014
Dr Phillip Probert
Dr Mohammed Ebrahimkhani
Dr Fiona Oakley
Professor Alastair Burt
Professor Derek Mann
et al.
Methapyrilene Treatment is a Refined Alternative to Bile Duct Ligation as a Model of Reproducible and Reversible Periportal Fibrosis in the Rat2013
Dr Mohammed Ebrahimkhani
Dr Fiona Oakley
Dr Jelena Mann
Dr Maria Perugorria
Dr Elizabeth Ellis
et al.
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease2011
Dr Roben Gieling
Dr Ahmed Elsharkawy
Dr David Cowie
Professor Matthew Wright
Dr Mohammed Ebrahimkhani
et al.
The c-Rel Subunit of Nuclear Factor-κB Regulates Murine Liver Inflammation, Wound-Healing, and Hepatocyte Proliferation2010
Dr Mohammed Ebrahimkhani
Professor Derek Mann
Dr Fiona Oakley
Pharmacological Blockade of 5HT 2B Receptor Stimulates Liver Growth2009
Dr Mohammed Ebrahimkhani
Professor Derek Mann
Dr Fiona Oakley
Serotonin 2B receptor: A novel negative regulator of liver growth2008
Dr Mohammed Ebrahimkhani
Dr Ahmed Elsharkawy
Professor Derek Mann
Wound healing and local neuroendocrine regulation in the injured liver2008
Dr Mohammed Ebrahimkhani
Dr Fiona Oakley
Professor Derek Mann
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats2006